CLSD - Clearside Biomedical GAAP EPS of -$0.11 in-line, revenue of $2.3M beats by $2.1M
2025-05-14 16:13:10 ET
More on Clearside Biomedical
- Clearside Biomedical, Inc. (CLSD) Q4 2024 Earnings Conference Call Transcript
- Clearside Biomedical Q1 2025 Earnings Preview
- Clearside outlines pivotal Phase 3 plans for CLS-AX in wet AMD
- Seeking Alpha’s Quant Rating on Clearside Biomedical
- Historical earnings data for Clearside Biomedical